A Rey
Impact in
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
- Oncology top 5%
- Lung Cancer Research Studies
- Ear and Head Tumors
- Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Sarcoma Diagnosis and Treatment 2
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Didier Cupissol (2 shared papers)S. Jelić (1 shared paper)Jan B. Vermorken (1 shared paper)Ahmad Awada (1 shared paper)Ricard Mesı́a (1 shared paper)Jacques Bernier (1 shared paper)Daniëlle Van den Weyngaert (1 shared paper)Thierry Gorlia (1 shared paper)
In The Last Decade
A Rey
11 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Otorhinolaryngology 926
- Oncology 707
- Pulmonary and Respiratory Medicine 642
- Surgery 758
- Cancer Research 249
Countries citing papers authored by A Rey
This map shows the geographic impact of A Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rey more than expected).
Fields of papers citing papers by A Rey
This network shows the impact of papers produced by A Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rey. The network helps show where A Rey may publish in the future.
Co-authors
The 25 scholars most cited alongside A Rey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer Hit paper breakdown → | 2007 | 1201 |
| 2 | 2000 | 231 | |
| 3 | 2012 | 135 | |
| 4 | Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy. | 2004 | 45 |
| 5 | 2014 | 27 | |
| 6 | 1998 | 27 | |
| 7 | A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors. | 1992 | 26 |
| 8 | 2000 | 23 | |
| 9 | 2008 | 10 | |
| 10 | 2013 | 6 | |
| 11 | 1997 | 1 |
About A Rey
A Rey is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Cancer Research, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Research Studies (4 papers), Ovarian cancer diagnosis and treatment (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Synthetic Organic Chemistry Methods (1 paper), Cancer Genomics and Diagnostics (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Otorhinolaryngology (926 citations), Oncology (707 citations), Pulmonary and Respiratory Medicine (642 citations), Surgery (758 citations) and Cancer Research (249 citations). A Rey has collaborated with scholars based in France, Italy and Russia. Frequent co-authors include Didier Cupissol, S. Jelić, Jan B. Vermorken, Ahmad Awada, Ricard Mesı́a, Jacques Bernier, Daniëlle Van den Weyngaert, Thierry Gorlia, Carla van Herpen and H. Kienzer. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, British Journal of Cancer, New England Journal of Medicine and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.